| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 40, 521-525, Copyright © 1993 by Canadian Anesthesiologists' Society
ARTICLES |
P Drolet and M Girard
Departement d'anesthesie-reanimation, Hopital Maisonneuve-Rosemont et Universite de Montreal, Quebec.
Maintenance of haemodynamic stability during anaesthesia for phaeochromocytoma resection is still a challenge. If magnesium sulfate is widely used for the control of arterial pressure during preeclampsia, its use during phaeochromocytoma resection has only been published by one author. We describe two cases where magnesium sulfate is the main agent used to control arterial pressure during resection of a phaeochromocytoma. Magnesium sulfate's hypotensive, antiarrhythmic and antiadrenergic properties are reviewed. The total doses administered were 11 g and 12 g, given as an infusion and boluses. Magnesium sulfate could be part of the anaesthetist's pharmacopoeia during phaeochromocytoma resection.
This article has been cited by other articles:
![]() |
M. F. James and L. Cronje Pheochromocytoma Crisis: The Use of Magnesium Sulfate Anesth. Analg., September 1, 2004; 99(3): 680 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Dube and J.-C. Granry The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review: [L'usage therapeutique du magnesium en anesthesiologie, reanimation et medecine d'urgence] Can J Anesth, August 1, 2003; 50(7): 732 - 746. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |